Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychophysiology of Delayed Extinction and Reconsolidation
NCT01631682Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2010
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of mifepristone, oxytocin nasal spray in post-traumatic stress disorder (PTSD), anxiety disorder, sponsored by Massachusetts General Hospital. Started Nov 2010; status: completed.
02
Drugs
mifepristoneoxytocin nasal spray
03
Conditions
post-traumatic stress disorder (PTSD)anxiety disorder
Beyond the preview
Go deeper on NCT01631682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01631682.